News (11/7/2018):
Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) ("Aleafia") or (the "Company") is announcing that it will hold a special meeting (the "Meeting") of shareholders on Thursday, December 6, 2018 at 9:00 a.m. (Toronto time) at Famee Furlane Club - Friuli Hall, 7065 Islington Avenue, Woodbridge, ON. L4L 1V9.
"Listing on the NASDAQ is another step as we continue the relentless execution of our stated goal of attaining a global leadership position in the cannabis space," said Aleafia Chairman Julian Fantino.
"Asking shareholders to approve a range for a possible share consolidation will provide management the flexibility to adjust the number of shares, but only if necessary, to achieve the minimum bid price requirements to complete our NASDAQ listing process," said Aleafia CEO Geoffrey Benic. "Management believes that listing on the NASDAQ will help to broaden our shareholder base, increase appeal to institutional investors, provide shareholders with better liquidity and, ultimately increase shareholder value, allowing Aleafia to rapidly accelerate our business strategy."
The meeting has been called for the following purposes:
-- To consider and, if thought appropriate, to pass a special resolution approving the consolidation of the Company's issued and outstanding common shares on a consolidation ratio of up to four (4) pre-consolidation common shares to one (1) post-consolidation common share;
-- The company believes that the share consolidation, if effected at all, would have a maximum of up to a 4:1 basis to assist in meeting minimum share price requirements of the NASDAQ listing which the company has applied for;
-- The company believes that the share consolidation, if effected at all, would have a maximum of up to a 4:1 basis to assist in meeting minimum share price requirements of the NASDAQ listing which the company has applied for;
-- Current issued and outstanding common shares for the Company are 145,518,851; if approved and effected, the issued and outstanding common shares on a post-consolidation basis would have a maximum effect of the company having a total number of shares issued of 36,379,712;
-- The Company would like to note that a share consolidation will not have an effect on the percentage ownership of each respective shareholder, as all common shares, and common share derivatives, would be subject to the same consolidation;
-- The Company believes that the post-consolidation market price per common share will make investing in the Company more attractive to a broader range of institutional investors and other members of the investing public;
-- The share consolidation is subject to shareholder approval and Exchange acceptance;
-- To consider and, if thought appropriate, to pass an ordinary resolution to approve certain amendments to the Company's stock option plan;
-- To consider and, if thought appropriate, to pass an ordinary resolution to approve certain amendments to the Company's restricted share unit plan; and
-- To transact any other business that may properly come before the Meeting.
Full details of the Meeting are set out in the Management Information Circular (the "Circular") dated November 6, 2018. A copy of the Circular and other meeting materials can be found under the Company's profile on SEDAR at www.sedar.com.
For Investor & Media Relations, please contact:
Nicholas Bergamini, VP, Public Affairs
IR@AleafiaInc.com
